•  
• Blogs
•  
• Afiliación
•  
• Publicaciones
•  
• Investigación
•  
• Contacto
•  
•  
• Informes
• Ver todos
•  

Afiliación

miembro de

• Organización Industrial Contribuyente
• Red Investigadores de Economía Miembro

Publicaciones

publicaciones seleccionadas

• artículo

  • A welfare analysis of genetic testing in health insurance markets with adverse selection and prevention 2025
  • Concentration of the mobile telecommunications markets and countries’ competitiveness 2022
  • Nursing‐homes' competition and distributional implications when the market is two‐sided 2021
  • Health Care Insurance Policies When the Provider and Patient May Collude 2021
  • Physicians’ Incentives to Adopt Personalized Medicine: Experimental Evidence 2021
  • Controlling Sellers Who Provide Advice: Regulation and Competition 2020
  • How is the Trade-off between Adverse Selection and Discrimination Risk Affected by Genetic Testing? Theory and Experiment 2019
  • Informality and Optimal Public Policy 2019
  • Médecine personnalisée, tests génétiques et assurance santé : une tension exacerbée entre antisélection et discrimination des risques 2017
  • Supplemental Health Insurance in the Colombian Managed Care System: Adverse or Advantageous Selection? 2017
  • Health Insurance and Diversity of Treatment 2016
  • Integración vertical en el sector colombiano de la salud 2016
  • The Design of Insurance Coverage for Medical Products Under Imperfect Competition 2016
  • Vertical Integration in the Colombian Healthcare Sector [Integración vertical en el sector colombiano de la salud] 2016
  • Competition between Health Maintenance Organizations and Nonintegrated Health Insurance Companies in Health Insurance Markets 2015
  • Hospital Variation in Cesarean Delivery: A Multilevel Analysis 2015
  • Unemployment Insurance in the Presence of an Informal Sector 2015
  • Competition in Two-Sided Markets with Common Network Externalities 2014
  • Competencia en el sector de la salud: énfasis en el caso colombiano 2013
  • Genetic Testing with Primary Prevention and Moral Hazard 2013
  • Doctors' Remuneration Schemes and Hospital Competition in a Two-Sided Market 2012
  • The Regulation of Health Care Providers’ Payments when Horizontal and Vertical Differentiation Matter 2012
  • Health Care Network Formation and Policyholders' Welfare 2011
  • Competition Among Health Plans: A Two-Sided Market Approach 2010
  • Retail Price Regulation and Innovation: Reference Pricing in the Pharmaceutical Industry 2010
  • La regulación de tarifas en el sector de la salud en Colombia 2007
  • Optimal Regulation of Health System with Induced Demand and 'Ex post' Moral Hazard 2006
  • Optimal Health Insurance Contract: Is a Deductible Useful? 2005
  • A Paradoxical Risk Aversion Effect on the Consumers' Demand for Quality 2004
  • Contrat d'assurance maladie optimal et risque moral ex ante. Quand peut-on s'affranchir d'une franchise? 2004
  • Estimation de l'efficience des dépenses de santé au niveau départemental par la méthode DEA 2004
  • Efficacité et risque moral ex post en assurance maladie 2003
  • Gestion des risques longs et comportements de risque moral sur les marchés d'assurance maladie la première inefficacité peut-elle éliminer la seconde? 2003
  • Demande induite et réglementation de médecins altruistes 2002

• documento de trabajo

  • A Welfare analysis of genetic testing in health insurance markets with adverse selection and prevention 2025
  • Incentivizing Physicians’ Diagnostic Effort and Test with Moral Hazard and Adverse Selection 2025
  • Incentivizing Physicians’ Diagnostic Effort and Test with Moral Hazard and Adverse Selection 2025
  • The Health Technology Assessment Approach of the Economic Value of Diagnostic Tests : A Literature Review 2025
  • Economic Incentives to Develop and to Use Diagnostic Tests - A Literature Review 2024
  • Economic Incentives to Develop and to Use Diagnostic Tests - A Literature Review 2024
  • Economic Incentives to Develop and to Use Diagnostic Tests a Literature Review 2024
  • Incentivizing Physicians' Diagnostic Effort and Test with Moral Hazard and Adverse Selection 2024
  • Incentivizing Physicians' Diagnostic Effort and Test with Moral Hazard and Adverse Selection 2024
  • The Health Technology Assessment Approach of The Economic Value of Diagnostic Test: A Literature Review 2024
  • The Health Technology Assessment Approach of the Economic Value of Diagnostic Tests - A Literature Review 2024
  • The Health Technology Assessment Approach of the Economic Value of Diagnostic Tests - A Literature Review 2024
  • Personalized Medicine and Prevention: Can Cross-Subsidies Survive in the Health Insurance Markets ? 2023
  • El trabajo intermediado por plataformas en Colombia: aspectos conceptuales y propuesta de regulación desde la teoría de contratos y la organización industrial 2022
  • Health care insurance payment policy when the provider and patient May Collude 2021
  • Coronavirus and Social Distancing: Do Non-Pharmaceutical-Interventions Work (at Least) in the Short Run? 2021
  • Coronavirus and Social Distancing: Do Non-Pharmaceutical-Interventions Work (at Least) in the Short Run? 2021
  • Coronavirus and Social Distancing: Do Non-Pharmaceutical-Interventions Work (at Least) in the Short Run? 2021
  • Physicians’ Incentives to Adopt Personalised Medicine: Experimental Evidence 2021
  • Price Cap Regulation in the Colombian Pharmaceutical Market: An Impact Evaluation 2021
  • Price Cap Regulation in the Colombian Pharmaceutical Market: An Impact Evaluation 2021
  • Concentration of the Mobile Telecommunications Markets and Countries' Competitiveness 2020
  • Controlling Sellers Who Provide Advice: Regulation and Competition 2019-02
  • Informality and optimal public policy 2019
  • Physicians’ Incentives to Adopt Personalized Medicine: Experimental Evidence 2018-11
  • Precios máximos de venta en el mercado de medicamentos colombiano: una evaluación de impacto 2018-10
  • Nursing Homes’ Competition and Distributional Implications when the Market is Two Sided 2018-07
  • Nursing Homes ‘Competition and Distributional Implications when the Market is Two-Sided 2018-06
  • How is the Trade off between Adverse Selection and Discrimination Risk Affected by Genetic Testing?: Theory and Experiment 2017
  • Drugs, Showrooms and Financial Products: Competition and Regulation when Sellers Provide Expert Advice 2016-11
  • Characterization of the Relevant Market in the Media Industry: Some New Evidence! 2016-10
  • Supplementary Health Insurance in the Colombian Managed Care System: Adverse or Advantageous Selection? 2016-10
  • Informality and Optimal Public Policy 2016-01
  • Integración vertical en el sector de la salud colombiano 2015-11
  • Voluntary Health Plan Subsidies and Public Expenditure 2015-10
  • Health Care Insurance Payment Policy when the Physician and Patient May Collude 2015-04
  • Welfare Impacts of Genetic Testing in Health Insurance Markets: Will Cross-Subsidies Survive? 2015-03
  • The Design of Insurance Coverage for Medical Products under Imperfect Competition 2015
  • Competencia en el sector de la salud: énfasis en el caso colombiano 2014-02
  • Adverse Selection vs Discrimination Risk with Genetic Testing: An Experimental Approach 2014
  • Unemployment Insurance in the Presence of an Informal 2013-09
  • Análisis económico de la normativa de libre competencia en Colombia 2013-05
  • Unemployment Insurance in the Presence of an Informal Sector 2013-01
  • Health Insurance and Diversity of Treatment: A Policy Mix Perspective 2013
  • La economía de los mercados de dos lados: aplicación al análisis de las tarjetas de pago en Colombia 2012-09
  • Competition between Managed Care Organizations and Indemnity Plans in Health Insurance Markets 2012-07
  • Genetic Testing with Primary Prevention and Moral Hazard 2012-05
  • The Regulation of Health Care Providers' Payments when Horizontal and Vertical Differentiation Matter 2012-01
  • Unemployment Insurance and Informality in Developing Countries 2011-10
  • Unemployment Insurance/Severance Payments and Informality in Developing Countries 2011-09
  • Doctors' Remuneration Schemes and Hospital Competition in Two-sided Markets with Common Network Externalities 2011-02
  • Health Care Network Formation and Policyholders' Welfare 2010-08
  • Health Care Providers Payments Regulation when Horizontal and Vertical Differentiation Matter 2010-03
  • Competition in Two Sided Markets with Common Network Externalities 2009-10
  • Small Area Variation in Health Care Affecting the Choice of Cesarean Delivery: The Case of a Colombian Health Insurer 2009-10
  • Retail Price Regulation and Innovation: Reference Pricing in the Pharmaceutical Industry 2009-07
  • Seguros de desempleo: revisión de literatura y propuesta para Colombia 2009-07
  • Competition Among Health Plans: A Two Sided Market Approach 2009-01
  • Teorías y algunas experiencias internacionales en el financiamiento de la educación superior: lecciones para Colombia 2008-05
  • ¿Tiene efectos negativos el TLC sobre los precios de los medicamentos y la salud de los colombianos? 2007-10
  • Teoría del control óptimo: ¡una guía para principiantes! 2005-12
  • A Paradoxical Risk Aversion Effect on the Consumers’ Demand for Quality 2004-03
  • Competition in Health Care Markets and Vertical Restraints 2004

Investigación

Palabras clave

• Economía de la salud
• Economía laboral
• Economía pública
• Organización industrial
• Política de la competencia

Contacto

nombre completo

• David
• Bardey